Holen Sie sich die Stockscreener-App
0.5357
4.36%
0.0224
Schlusskurs vom Vortag:
$0.5133
Offen:
$0.53
24-Stunden-Volumen:
719.58K
Relative Volume:
1.10
Marktkapitalisierung:
$83.71M
Einnahmen:
$70.99M
Nettoeinkommen (Verlust:
$-35.48M
KGV:
-1.0714
EPS:
-0.5
Netto-Cashflow:
$-20.86M
1W Leistung:
+45.97%
1M Leistung:
-30.55%
6M Leistung:
-51.74%
1J Leistung:
-55.36%
1-Tages-Spanne:
$0.5138
$0.5766
1-Wochen-Bereich:
$0.36
$0.5766
52-Wochen-Spanne:
$0.321
$2.10
Optinose Inc Stock (OPTN) Company Profile
Firmenname
Optinose Inc
Sektor
Telefon
267-364-3500
Adresse
777 TOWNSHIP LINE ROAD, YARDLEY, PA
Vergleichen Sie OPTN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OPTN
Optinose Inc
|
0.5357 | 83.71M | 70.99M | -35.48M | -20.86M | -0.50 |
|
ZTS
Zoetis Inc
|
176.74 | 80.59B | 9.15B | 2.43B | 2.31B | 4.92 |
|
HLN
Haleon Plc Adr
|
9.72 | 44.17B | 14.26B | 1.55B | 0 | 0.3327 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.57 | 42.61B | 30.27B | 1.93B | 3.45B | 0.444 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.57 | 18.77B | 16.77B | -959.00M | 1.37B | -2.00 |
|
VTRS
Viatris Inc
|
13.22 | 15.73B | 15.05B | -883.30M | 1.89B | 1.53 |
Optinose Inc Stock (OPTN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-03-11 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-08-21 | Eingeleitet | Lake Street | Buy |
| 2022-10-21 | Fortgesetzt | Jefferies | Buy |
| 2021-04-07 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2019-12-18 | Eingeleitet | Cowen | Outperform |
| 2018-08-08 | Eingeleitet | Cantor Fitzgerald | Overweight |
Alle ansehen
Optinose Inc Aktie (OPTN) Neueste Nachrichten
OptiNose, Inc. (NASDAQ:OPTN) Might Not Be As Mispriced As It Looks After Plunging 31% - Simply Wall St
91,084 Shares in OptiNose, Inc. (NASDAQ:OPTN) Acquired by GSA Capital Partners LLP - Defense World
Stonepine Capital Management, LLC Increases Stake in OptiNose Inc - GuruFocus.com
OptiNose (OPTN) Reports Break-Even Earnings for Q3 - MSN
OptiNose (STU:0OP) Owner Earnings per Share (TTM) : -0.31 (As of Sep. 2024) - GuruFocus.com
Optinose to Announce Q3 2024 Financial Results with Investor Call - MSN
OptiNose (STU:0OP) 5-Year EBITDA Growth Rate : 41.10% (As of Sep. 2024) - GuruFocus.com
OptiNose stock plunges to 52-week low at $0.37 amid market challenges - Investing.com
FY2024 EPS Estimates for OptiNose Increased by HC Wainwright - Defense World
Earnings Release: Here's Why Analysts Cut Their OptiNose, Inc. (NASDAQ:OPTN) Price Target To US$3.50 - Simply Wall St
OptiNose, Inc. (NASDAQ:OPTN) Just Reported, And Analysts Assigned A US$3.50 Price Target - Yahoo Finance
FY2024 EPS Estimates for OptiNose Raised by HC Wainwright - MarketBeat
Great Point Partners LLC Bolsters Position in OptiNose Inc - GuruFocus.com
HC Wainwright Reaffirms Buy Rating for OptiNose (NASDAQ:OPTN) - Defense World
OptiNose Third Quarter 2024 Earnings: EPS: US$0.002 (vs US$0.083 loss in 3Q 2023) - Yahoo Finance
Optinose stock target down as analyst cites challenges in Xhance sales guidance - Investing.com UK
Optinose Reports Q3 2024 Financial Results, Highlights XHANCE Performance - MyChesCo
OptiNose (NASDAQ:OPTN) Given Buy Rating at HC Wainwright - MarketBeat
OptiNose, Inc. (NASDAQ:OPTN) Q3 2024 Earnings Call Transcript - Insider Monkey
OptiNose Inc (OPTN) Q3 2024 Earnings Call Highlights: Revenue Gr - GuruFocus.com
OptiNose Inc (OPTN) Q3 2024 Earnings Call Highlights: Revenue Growth Amid Revised Guidance - Yahoo Finance
FMR LLC's Strategic Acquisition of OptiNose Inc Shares - GuruFocus.com
OptiNose Inc (OPTN) Quarterly 10-Q Report - Quartzy
OptiNose stock hits 52-week low at $0.63 amid market challenges - Investing.com
Optinose Reports Third Quarter 2024 Financial Results and Recent Operational Highlights - The Manila Times
Optinose Slashes 2024 Revenue Guidance Despite Q3 Growth; XHANCE Sales Up 3% | OPTN Stock News - StockTitan
OptiNose Inc (OPTN) Q3 2024 Earnings Report Preview: What To Exp - GuruFocus.com
OptiNose (OPTN) Scheduled to Post Earnings on Tuesday - MarketBeat
Optinose (OPTN) Sets Q3 2024 Earnings Call for November 12What to Expect | OPTN Stock News - StockTitan
Optinose Announces Reporting Date for Third Quarter 2024 Financial Results - GlobeNewswire
Intranasal Drug and Vaccine Delivery Market is Expected to Soar - openPR
Head to Head Review: OPKO Health (NASDAQ:OPK) vs. OptiNose (NASDAQ:OPTN) - Defense World
Insiders In OptiNose Left Out From 19% Price Rise After Disposing Stock - Simply Wall St
Positive week for OptiNose, Inc. (NASDAQ:OPTN) institutional investors who lost 24% over the past year - Yahoo Finance
Rosalind Advisors, Inc. Expands Stake in OptiNose Inc - GuruFocus.com
Optinose Grants Stock Options to Attract New Talent - MSN
OptiNose faces potential Nasdaq delisting over share price - Investing.com India
OptiNose faces potential Nasdaq delisting over share price By Investing.com - Investing.com Australia
Optinose Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Squarepoint Ops LLC Has $178,000 Position in OptiNose, Inc. (NASDAQ:OPTN) - Defense World
OptiNose Inc (OPTN) Q2 2024 Earnings Call Highlights: Revenue Growth and Strategic Shifts Amid ... - Yahoo Finance
Optinose Appoints Terry Kohler as Chief Financial Officer - MyChesCo
OptiNose Names Terry Kohler New CFO with Incentive Grant - TipRanks
Optinose names Terry Kohler as new CFO - Investing.com
Optinose Names Terry Kohler as CFO - MarketWatch
Optinose names Terry Kohler as new CFO By Investing.com - Investing.com UK
Finanzdaten der Optinose Inc-Aktie (OPTN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.83%
1.03%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):